India currently contributes three-to-five per cent share of the global biotechnology sector
The outsourcing market size for CDMOs in India is roughly at Rs 20,000 crores and it is expected to grow to about Rs 40,000 crores…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Windlas Biotech
Path to progress
On India’s 75th Independence Day, a few stakeholders and their partners share their insights on the biggest achievements and…
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform
Interim data from clinical trials show PulmoHeal’s efficacy in improving recovery of mild and moderate Covid-19 patients
Windlas Biotech, Mateon Therapeutics partner to launch combined lung therapy and AI telemedicine…
The solution consists of three components: the drug PulmoHeal, an AI lung health assessment tool called ArtiHealthand, a…
We might need to redefine our approach to drug discovery and approval to be prepared for the future
Hitesh Windlass, MD, Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his…
Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr
The sale is expected to be completed within 10 business days